Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.384, 2002-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Validity of Cost and Utility Results?
PharmacoEconomics, Vol. 30, Iss. 10, 2012-10 ,pp. :
Access to resources
Recommend
Ramipril, rosiglitazone for atherosclerosis: STARR results?
Inpharma, Vol. 1, Iss. 1585, 2007-01 ,pp. :
A ready remedy for rheumatoid arthritis realised in R 788 results?
Inpharma, Vol. 1, Iss. 1619, 2008-01 ,pp. :
Time to reconsider the risks of HRT?
Reactions Weekly, Vol. 1, Iss. 1425, 2012-01 ,pp. :
Wyeth's HRT prescription sales drop following release of trial results
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 383, 2002-01 ,pp. :